In situ detection of cyclic AMP-phosphodiestrease activity in the heart of Lewis and Sprague-Dawley rats: The effect of restraint stress or amphetamine application

Histology and Histopathology

Volumn 19, Issue 3, 2004, Pages 719-726

  Okruhlicova L ^a   Klenerova V ^b   Hynie, S ^b   Sida P ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Amphetamine; Cytochemistry; Heart restraint stress; Phosphodiesterase

Indexed keywords

ADENYLATE CYCLASE; AMPHETAMINE; CYCLIC AMP PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; EXPOSURE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART STRESS; HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; MALE; MICROVASCULATURE; NONHUMAN; RAT; RAT STRAIN; SARCOPLASMIC RETICULUM; SENSITIVITY ANALYSIS; VASCULAR ENDOTHELIUM;

AMPHETAMINES; ANIMALS; CAPILLARIES; CELL MEMBRANE; CYCLIC AMP; ENDOTHELIUM, VASCULAR; HEART VENTRICLES; HISTOCYTOCHEMISTRY; IMMOBILIZATION; INJECTIONS, INTRAPERITONEAL; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SARCOLEMMA; SARCOPLASMIC RETICULUM; SPECIES SPECIFICITY; STRESS; TIME FACTORS;

ANIMALIA;

EID: 3042740789     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Barbato J.C., Koch L.G., Darvish A., Cicila G.T., Metting P.J. and Britton S.L. (1998). Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J. App. Physiol. 85, 530-536.
2. Barbato J.C., Lee S.J., Koch L.G. and Cicila G.T. (2002). Myocardial function on rat genetic models of low and high aerobic running capacity. Am. J. Physiol. Regulatory Intergrative Comp. Physiol. 282, R721-R726.
3. Beavo J.A. and Reifsnyder D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11, 150-155.
4. Beavo J.A., Conti M. and Heaslip R.J. (1994). Multiple nucleotide phosphodiesterases. Mol. J. Pharmacol. 46, 399-405.
5. Beltman J., Sonnenburg W.K. and Beavo J.A. (1993). The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol. Cell. Biochem. 127/128, 239-253.
6. Conti M., Jin S.L.C., Monaco L., Repaske D.R. and Swinnen J.V. (1991). Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocrine Rev. 12, 218-233.
7. De Mello W.C. (1988). Cyclic nucleotided and junctional permeability. In: Gap Junctions: Proceedings of the International Conference on Gap Junctions. Hertzberg E.L. and Johnson R. (eds). Alan R. Liss, Inc. New York. pp 245-254.
8. Darow B.J., Fast V.G., Kleber A.G., Beyer E.C. and Saffitz J.E. (1996). Functional and structural assessment of intercellular communication. Circ. Res. 79, 174-183.
9. Eckly A. and Lugnier C. (1994). Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol. 113, 445-450.
10. Gallardo-Carpentier A., Aileru A.A. and Carpentier R.G. (1997). Arrhythmogenic and antiarrhythmogenic actions of substances of abuse: effects on triggered activity. J. Electrocardiol. 30, 137-142.
11. Hynie S., Klenerova V., Caicedo M. and Samanek M. (1996). Differences in response to activation of adenylate cyclase by various stimulants in human myocardium. Mol. Cell. Biochem. 163-164, 329-333.
12. Jurevicius J. and Fishmeister R. (1996). cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc. Natl. Acad. Sci. USA 93, 295-299.
13. Kaminsky O., Klenerova V., Stöhr J., Sida P. and Hynie S. (2001). Differences in the behaviour of Sprague-Dawley and Lewis Rats during repeated passive avoidance procedure: effect of amphetamine. Pharmacol. Res. 44, 117-122.
14. Katz A.M. (1982). Regulation of cardiac contractile activity by cyclic nucleotides. In: Cyclic nucleotides. Part II: Physiology and pharmacology. Kebabian J.W. and Nathanson J.A. (eds). Springer Verlag Berlin Heidelberg New York, pp. 347-364.
15. Katz A.M., Tada M., Repke D.I., Iorio J.M. and Kirchberger M.A. (1974). Adenylate cyclase: its probable localisation in sarcoplasmic reticulum as well as sarcolemma of canine heart. J. Mol. Cell. Cardiol. 6, 73-79.
16. Khananashvili M.M. and Karsanov N.V. (1987). Subcellular bases of cardiac disturbance in experimental informational neurosis. Int. J. Psychophysiol. 4, 307-318.
17. Klenerova V., Sida P. and Hynie S. (1998). Different activity of adenylyl cyclase in prefrontal cortex in three rat strains. The effect of amphetamine. Folia Biol. (Praha) 44, 133-136.
18. Klenerova V., Sida P., Engliova D., Stohr J., Nazarov E., Kaminsky O. and Hynie S. (1999). Effects of immobilization stress combined with water immersion and chronic amphetamine treatment on the adenylyl cyclase activity in rat neurohypophysis. Physiol. Res. 48, 513-517.
19. Klenerova V., Jurcovicova J., Kaminsky O., Sida P., Krejci I., Hlinak Z. and Hynie S. (2003). Combined restraint and cold stress in rats: effect on memory processing in passive avoidance task and on plasma levels of ACTH and corticosterone. Behav. Brain Res. 142, 143-149.
20. Klenerova V., Kaminsky O., Sida P., Krejci I., Hlinak Z. and Hynie S. (2002). Impaired passive avoidance acquisition in Sprague-Dawley and Lewis rats after restraint and cold stress. Behav. Brain Res. 136, 21-29.
21. Klenerova V., Sida P., Hynie S. and Zídek Z. (1997). The effect of LPS and chronic amphetamine treatment on cyclic AMP system in the heart rat. Arch. Physiol. Biochem. 105, 244.
22. Krause E.G., Ziegelhoffer A., Fedelesova M., Styk J., Kostolansky S., Gabauer I., Blasig I. and Wollenberger A. (1978). Myocardial cyclic nucleotide levels following coronary artery ligation. Adv. Cardiol. 25, 119-129.
23. Lugnier C., Muller B., Le Bec A., Beaudri C. and Rousseau E. (1993). Cyclic nucleotide phosphodiesterase in canine and human cardiac microsomal fractions. J. Pharmacol. Exp. Ther. 265, 1142-1151.
24. Miroshnichenko V.P., Kashtanov S.I., Libova P.M. and Zubovskaia A.M. (1983). Acute emotional stress and cyclic nucleotide content of the heart and blood plasma. Biull. Eksp. Biol. Med. 95, 21-23.
25. Nagaraja H.S. and Jeganathan P.S. (1999). Influence of different types of stress on selected cardiovascular parameters in rats. Indian J. Physiol. Pharmacol. 43, 296-304.
26. Okada F., Honma M. and Ui M. (1983). Plasma cyclic nucleotide responses to psychological stress in normal and neurotic patients. J. Clin. Endocrinol. Metab. 57, 78-81.
27. Okruhlicova L., Tribulova N., Eckly A., Lugnier C. and Slezak J. (1996). Cytochemical distribution of cyclic AMP-dependent 3′, 5′-nucleotide phosphodiesterase in the rat myocardium. Histochem. J. 28, 165-172.
28. Okruhlicova L., Tribulova N., Styk J., Eckly A., Lugnier C. and Slezak J. (1997). Species differences in localization of cardiac cAMP-phosphodiesterase activity: a cytochemical study. Mol. Cell. Biochem. 173, 183-188.
29. Okruhlicova L., Slezák J., Tribulová N. and Ficková M. (1988a). Changes of myocardial adenylate cyclase activity in early phases of ischemia. Bratisl. lek. Listy 89, 240-244.
30. Okruhlicova L., Vrbjar N. and Lugnier C. (1998b). Characterization of type 4 cyclic nucleotide phosphodiesterase in cardiac sarcolemma. Exp. Clin. Cardiol. 3, 188-192.
31. Okruhlicova L., Ravingerova T., Pancza D., Tribulova N., Styk J. and Stetka R. (2000). Activation of adenylate cyclase system in preconditioned rat heart. Physiol. Res. 49, 251-259.
32. Petkova I. and Milkov V. (1991). Stress-induced changes in the cyclic nucleotide concentrations and phosphorylase activity in the myocardium. Acta Physiol. Pharmacol. BuIg. 17, 129-134.
33. Roth D.A., White C.D., Podolin D.A. and Mazzeo R.S. (1998). Alterations in myocardial signal transduction due to aging and chronic dynamic exercise. J. Appl. Physiol. 84, 177-184.
34. Shahid M. and Nicholson C.D. (1990). Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: Positive inotropic and phosphodiestrase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn-Schmied Arch. Pharmacol. 342, 698-704.
35. Shahid M., Wilson M., Nicholson C.D. and Marshall R.J. (1990). Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. J. Pharm. Pharmacol. 42, 282-288.
36. Sida P., Klenerova V. and Hynie S. (2003). Differences in adenylyl cyclase activity in myocardium of various inbred strains of rats. Physiol. Res. 52, 40P.
37. Simpson L.L. (1975). Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation. J. Pharmacol. Exp. Ther. 193, 149-159.
38. Schulze W. (1984). Mehods for histochemical localization of adenylate cyclase and guanylate cyclase in heart membrane. In: Methods studying cardiac membranes. Vol. II. Dhalla N.S. (ed.). Florida: CRS Press, Inc Boca Raton. pp. 83-97.
39. Slezak J. and Geller A.G. (1979). Cytochemical demonstration of adenylate cyclase in cardiac muscle. Effect of dimethyl sulfoxide. J. Histochem. Cytochem. 27, 774-781.
40. Spaber S.B. and Fossom L.H. (1984). Amphetamine cumulation and tolerance development: Concurrent and opposing phenomena. Pharmacol. Biochem. Behav. 4, 415-424.
41. Szekeres L. (1996). On the mechanism and possible therapeutic application of delayed cardiac adaptation to stress. Can. J. Cardiol. 2, 177-185.
42. Tribulova N., Ravingerova T., Okruhlicova L., Gabauer I., Fickova M., Pancza D., Slezak J. and Manoach M. (2000). Modulation of cAMP level by tedisamil in guinea pig heart. Mol. Cell. Biochem. 210, 75-80.